title: [Pure and diluted contrast media in the visualization of the portal venous system using digital angiography].
abstract: We report the results of intra-arterial digital subtraction angiography (DSA) in 100 patients with portal hypertension. The portal venous system was evaluated; all patients underwent angiography of the celiac and superior mesenteric arteries before surgery. Forty-four of them were also examined after Warren splenorenal shunts. Therefore, a total of 144 exams was evaluated. The authors always employed low-osmolality ionic and non-ionic contrast media (iodine concentration: 300-350 mg/ml). In 70 cases pure contrast medium was injected (20-25 ml); in the extant 74 cases it was diluted with an equal volume of saline solution (osmolality and iodine concentration reduced by 50%). Intra-arterial DSA always visualized portal venous system, collateral circulation, shunt location and postoperative changes. The major advantage of intra-arterial DSA is the smaller amount of contrast medium injected, so that local and systemic side effects are rare. According to our experience, it is best to dilute the contrast medium and inject the same amount as in conventional angiography, at the same rate. Other well-known advantages of intra-arterial DSA are quicker execution, less injury to arteries using smaller-caliber catheters, and low cost. The major disadvantage of intra-arterial DSA, as it appeared also in our study, is the field size of the intensifier, which in our case was limited to 6-9 inches. This is an insufficient coverage for the whole portal system to be studied, and some contrast medium injections become therefore necessary. An average of 3 injections were given to each patient. This problem reduces the advantage of less contrast medium per injection. At any rate, even though intra-arterial DSA exhibits this limitation, it can nevertheless yield important information in the pre- and postoperative evaluation of patients with portal hypertension.
authors.affiliation: Istituto di Scienze Radiologiche, Università, Ospedale San Paolo, Milano.
authors.forename: F
authors.initials: F
authors.lastname: Gattoni
authors.forename: U
authors.initials: U
authors.lastname: Baldini
authors.forename: C
authors.initials: C
authors.lastname: Pozzato
authors.forename: R
authors.initials: R
authors.lastname: Nessi
authors.forename: R
authors.initials: R
authors.lastname: Raiteri
authors.forename: E
authors.initials: E
authors.lastname: Opocher
authors.forename: R
authors.initials: R
authors.lastname: Santambrogio
authors.forename: C
authors.initials: C
authors.lastname: Uslenghi
mesh_terms: D000328:Adult; D000368:Aged; D015901:Angiography, Digital Subtraction; D003287:Contrast Media / Q000008:administration & dosage*; D005260:Female; D006801:Humans; D006975:Hypertension, Portal / Q000000981:diagnostic imaging* / Q000601:surgery; D008297:Male; D008875:Middle Aged; D009994:Osmolar Concentration; D011168:Portal System / Q000000981:diagnostic imaging*
chemical_list: D003287:Contrast Media
vernacular_title: Mezzo di contrasto puro e diluito nella dimostrazione del sistema venoso portale con angiografia digitale.